Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview 2022-2027:

The global molecular cytogenetics market size reached US$ 2.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2027, exhibiting a growth rate (CAGR) of 10.32% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based  on product type, technology, application and end user.

Breakup by Product Type:

  • Instruments
  • Consumables
  • Software and Services
  • Others
     

Breakup by Technology:

  • Comparative Genomic Hybridization
  • Fluorescence in SITU Hybridization (FISH)
  • Immunohistochemistry
  • Karyotyping
  • Others
     

Breakup by Application:

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Others
     

Breakup by End User:

  • Clinical and Research Laboratories
  • Hospitals and Pathology Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Type, Technology, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology
 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Molecular Cytogenetics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Instruments
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Consumables
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Software and Services
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Technology
    7.1    Comparative Genomic Hybridization
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Fluorescence in SITU Hybridization (FISH)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunohistochemistry
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Karyotyping
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Application
    8.1    Genetic Disorders
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Oncology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Personalized Medicine
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by End User
    9.1    Clinical and Research Laboratories
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospitals and Pathology Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Pharmaceutical and Biotechnology Companies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Agilent Technologies Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Applied Spectral Imaging Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
        15.3.4    Biological Industries
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
        15.3.5    Bio-RAD Laboratories Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    BioView Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
        15.3.7    Danaher Corporation
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials 
           15.3.7.4 SWOT Analysis
        15.3.8    F. Hoffmann-La Roche AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 SWOT Analysis
        15.3.9    Illumina Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials 
           15.3.9.4 SWOT Analysis
        15.3.10    Oxford Gene Technology
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials 
        15.3.11    Perkinelmer Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials 
           15.3.11.4 SWOT Analysis
        15.3.12    Quest Diagnostics Incorporated
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials 

List of Figures

Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2021
Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2021
Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2021
Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2021
Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2021
Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
Figure 93: Global: Molecular Cytogenetics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Molecular Cytogenetics Market Structure
Table 8: Global: Molecular Cytogenetics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global molecular cytogenetics market was valued at US$ 2.2 Billion in 2021.

We expect the global molecular cytogenetics market to exhibit a CAGR of 10.32% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic had led to postponement of various malignant tumors and hematological malignancies diagnosis and treatment to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby limiting the demand for molecular cytogenetics.

The rising prevalence of cancer and other genetic disorders, along with the growing adoption of molecular cytogenetics for developing predictive models of disease traits and effective treatment strategies, is primarily driving the global molecular cytogenetics market.

Based on the product type, the global molecular cytogenetics market has been segmented into instruments, consumables, software and services, and others. Currently, consumables hold the majority of the total market share.

Based on the technology, the global molecular cytogenetics market can be divided into comparative genomic hybridization, Fluorescence in SITU Hybridization (FISH), immunohistochemistry, karyotyping, and others, where comparative genomic hybridization currently exhibits a clear dominance in the market.

Based on the application, the global molecular cytogenetics market has been categorized into genetic disorders, oncology, personalized medicine, and others. Currently, oncology accounts for the majority of the global market share.

Based on the end user, the global molecular cytogenetics market can be segregated into clinical and research laboratories, hospitals and pathology laboratories, pharmaceutical and biotechnology companies, and others. Among these, clinical and research laboratories hold the largest market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global molecular cytogenetics market include Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc., and Quest Diagnostics Incorporated.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4